These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5691595)

  • 1. Iron metabolism in Wilson's disease. Kinetic studies with iron.
    O'Reilly S; Pollycove M; Bank WJ
    Neurology; 1968 Jul; 18(7):634-44. PubMed ID: 5691595
    [No Abstract]   [Full Text] [Related]  

  • 2. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
    Petera V; Lahn V; Virt S; Voleníková L; Kohout J
    Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper.
    O'Reilly S; Pollycove M; Tono M; Herradora L
    Arch Neurol; 1971 Jun; 24(6):481-8. PubMed ID: 5089893
    [No Abstract]   [Full Text] [Related]  

  • 4. Excessive iron storage in a patient with Wilson's disease.
    Hafkemeyer P; Schupp M; Storch M; Gerok W; Häussinger D
    Clin Investig; 1994 Jan; 72(2):134-6. PubMed ID: 8186659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 7. [Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage].
    Degli Esposti A; Antener I; Ambrosioni G; Bonfiglioli G
    Minerva Pediatr; 1976 Nov; 28(34):2063-86. PubMed ID: 1012227
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homo- and heterozygotic differentiation in Wilson's disease].
    Abendschein T; Przuntek H; Wesch H; Gäng V
    Verh Dtsch Ges Inn Med; 1975; 81():1336-9. PubMed ID: 1226956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
    Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
    Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver-thigh 64Cu ratio in Wilson's disease.
    Levi AJ; Williams HS
    Clin Sci; 1968 Apr; 34(2):379-83. PubMed ID: 5690128
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease: does iron metabolism impact phenotypic presentation?
    Litwin T; Gromadzka G; Członkowska A
    Liver Int; 2012 May; 32(5):869-70; author reply 870. PubMed ID: 22292432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fundamentals of iron metabolism].
    Fleischhacker H
    Landarzt; 1967 Mar; 43(9):406-12. PubMed ID: 5594038
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of Wilson's disease in asymptomatic patients.
    Sternlieb I; Scheinberg IH
    N Engl J Med; 1968 Feb; 278(7):352-9. PubMed ID: 5635646
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 19. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
    Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
    J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.